ReviewDiscover nano2026
Nanotechnological applications of marine algae derived neurotoxins spanning harmful algal blooms and therapeutic innovations.
Review in Discover nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Marine algae-derived neurotoxins, commonly associated with harmful algal blooms (HABs), represent a paradox in marine and biomedical sciences. While traditionally studied for their ecological disruptions and health hazards, these bioactive compounds possess unique biochemical properties with promising therapeutic and technological applications. By summarizing current knowledge and identifying gaps in research, this review systematically examines the biological significance of marine algae, elucidates the mechanisms underlying neurotoxin production, and assesses their biomedical relevance. Furthermore, it explores nanotechnology as a transformative approach for harnessing neurotoxins in drug delivery, biosensing, and theranostics. Particular emphasis is placed on nano-biosensors for precise neurotoxin detection, nanomaterial-based mitigation strategies for HABs, and the use of neurotoxin-loaded nanocarriers in targeted pharmacological interventions. Ethical and environmental considerations surrounding neurotoxin utilization are critically analyzed to ensure sustainable applications. By synthesizing current knowledge and identifying gaps in research, this review hypothesizes that marine algae-derived neurotoxins, when incorporated into nanosystems, can serve as multifunctional agents in precision medicine, neuropharmacology, and diagnostic imaging. Through an interdisciplinary perspective bridging marine biology, toxicology, and nanoscience, this work aims to provide a structured framework for future research, fostering innovation at the intersection of marine biotechnology and nanomedicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.